Stakeholders build capacity for local production of WHO pre-qualified medicines Post published:September 22, 2023 Post category:Uncategorized Concerned that none of the over 120 pharmaceutical manufacturers in the country is pre-qualified by the World Health Organisation (WHO) to produce medicines for global procurement and use, stakeholders have renewed their efforts to address the gaps. Please Share This Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window You Might Also Like NNMDA Leads Innovative Fight Against River Blindness and Sleeping Sickness Through New MoU with NITR January 8, 2026 Prof. Martins Emeje On Maximizing Traditional Medicine | NTA September 2, 2024 Global Exposure for Local Impact: NNMDA Advances Staff Capacity August 1, 2025
NNMDA Leads Innovative Fight Against River Blindness and Sleeping Sickness Through New MoU with NITR January 8, 2026